Skip to main content

Table 1 Characteristics of the study patients

From: Levosimendan for resuscitating the microcirculation in patients with septic shock: a randomized controlled study

 

Levosimendan (n = 20)

Control (n = 20)

P value

Age, years

68 (55; 74)

66 (54; 78)

0.98

Gender, male

70%

65%

1.00

SAPS II

55 (45; 61)

57 (46; 64)

0.90

Cause of septic shock

Endocarditis (n = 1)

Peritonitis (n = 8)

Pneumonia (n = 11)

Peritonitis (n = 4)

Pneumonia (n = 16)

0.10

Onset of septic shock, hoursa

20 (18; 24)

18 (13; 22)

0.13

ICU mortality

13/20

15/20

0.50

ICU length of stay, days

14 (11; 19)

27 (9; 47)

0.32

  1. Data are presented as median (25th; 75th percentile). Control, dobutamine 5 μg/kg per minute. aOnset of septic shock defines the time elapsed from the onset of septic shock until administration of study drug. ICU, intensive care unit; SAPS II, Simplified Acute Physiology Score II.
Back to article page

Critical Care

ISSN: 1364-8535